
E212: The Ethics of AI
From AI For Pharma Growth by Dr Andree Bates
April 7, 2026 · 18 min · Episode 212
About this episode
The episode discusses the urgent necessity of AI ethics in healthcare and business, featuring insights from Dr Nadia Morozova on building trust and responsible AI practices.
AI ethics has moved from theory to urgent necessity, especially as AI systems become embedded in healthcare, business decisions, and society at large. In this episode, Dr Andree Bates is joined by Dr Nadia Morozova , founder of Enriched Insights , to unpack what ethical AI really means in practice, and how organisations can innovate quickly without creating risk, bias, or governance failures. Nadia shares insights from the global conversation on AI ethics, including discussions at Davos, and explains why trust is becoming the true competitive advantage. She argues that organisations should use AI to build stronger, more open relationships with customers and stakeholders, where technology acts as an enabler rather than the centrepiece. The conversation then gets practical. Nadia outlines a human-centric framework for high-quality AI outcomes, covering accurate sampling, futureproofing (because models are trained on the past), data connectivity across sources, and responsible blending of human and synthetic data. She warns that leadership teams often treat AI as “magic”, assuming tools will solve complex problems like data harmonisation without the hard work of ontology…
People in this episode
Host: Dr Andree Bates
Guest: Dr Nadia Morozova
Topics covered
- AI ethics
- healthcare
- business decisions
- trust
- human-centric framework
- data governance
Keywords
- AI ethics
- healthcare
- trust
- data governance
- human-centric AI
- Zillow case
- bias
- innovation
Mentioned in this episode
Organizations: Enriched Insights
Products: Zillow
More episodes of AI For Pharma Growth
- E221: The Diagnostic Room: The AI Governance Timeline Moved. Your Governance Exposure Didn't · June 9, 2026 · 28 min
- E220: The Intelligence Gap: Why Pharma's Biggest Deals Are Being Lost Before They Even Know They're Competing · June 2, 2026 · 23 min
- E219: Bridging the Data-Use Divide: How QuadraticMed’s Dr. Danielle Bower Bridges Medicine and Data Science to Unlock Real-World Evidence · May 26, 2026 · 36 min
- E218: How astrophysics methods used to study dark matter are now being applied to model cancer biology · May 19, 2026 · 32 min
- E217: The Diagnostic Room: Pilot purgatory: why pharma AI stalls after the first wins · May 12, 2026 · 47 min
- E216: When AI meets Cell Engineering · May 5, 2026 · 31 min
Explore listener stats, chart rankings, contacts and more on the AI For Pharma Growth podcast page.